Botulin-A Toxin Instillations and Overactive Bladder

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

March 31, 2006

Primary Completion Date

May 31, 2008

Study Completion Date

May 31, 2008

Conditions
Overactive BladderDetrusor InstabilityDetrusor Hyperreflexia
Interventions
DRUG

Botulinum-A toxin

A simple bladder catheterization in the office with a standard urinary catheter and instill the Botulinum-A toxin/DMSO solution.

DRUG

Dimethyl sulfoxide (DMSO)

Subjects received 50 cc of DMSO in an aqueous solution for intravesical instillation with botulinum-A toxin. Each cc contained 0.54 gm DMSO.

Trial Locations (1)

32224

Mayo Clinic Jacksonville, Jacksonville

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Mayo Clinic

OTHER